Company Name: |
Daicel Chiral Technologies (China)CO.,LTD
|
Tel: |
021-50460086-9 15921403865 |
Email: |
han_yajun@dctc.daicel.com |
Products Intro: |
Product Name:1a-methyl-7a-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)-1a,7a-dihydronaphtho[2,3-b]oxirene-2,7-dione CAS:2469735-68-8 Purity:95% HPLC Package:10MG ;25MG;50MG;100MG Remarks:DCTI-C-1159
|
Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
Tel: |
010-010-52878169 15801002657 |
Email: |
sales@bjcomparison.com |
Products Intro: |
Product Name:methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate CAS:2469735-68-8 Purity:>=95% Package:100mg/;50mg/;25mg/;10mg/
|
methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate manufacturers
- Nicardipine Impurity 8
-
- $0.00 / 10mg
-
2024-08-16
- CAS:2469735-68-8
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
| methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate Basic information |
Product Name: | methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate | Synonyms: | methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate;Nicardipine Impurity 08;Nicardipine Impurity84;Nicardipine Impurity 21;methyl 5-hydroxy-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate;3-Cyclohexene-1-carboxylic acid, 4-methyl-6-(3-nitrophenyl)-2-oxo-, methyl ester;Nicardipine EP Impurity 8;Nicardipine EP Impurity 9 | CAS: | 2469735-68-8 | MF: | C15H15NO5 | MW: | 289.28 | EINECS: | | Product Categories: | | Mol File: | 2469735-68-8.mol | |
| methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate Chemical Properties |
Boiling point | 419.3±45.0 °C(Predicted) | density | 1.269±0.06 g/cm3(Predicted) | pka | 9.99±0.60(Predicted) |
| methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate Usage And Synthesis |
| methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate Preparation Products And Raw materials |
|